Fleming Companies, Inc

Leonard A. Lauder Decides Not to Stand for Re-Election to The Estée Lauder Companies Board of Directors

Retrieved on: 
Thursday, August 24, 2023
Cosmetics, Retail, Luxury, Fashion, Marketing, Whitney Museum, Lauder, Council, Aveda, Wharton School of the University of Pennsylvania, Le Labo, Foreign policy, Origin, DECIEM, Management, BS, Beauty, University, Penn State Board of Trustees, Politics, Whitney, Aspen, Memorial, Breast Cancer Research Foundation, Growth, Entrepreneurship, Aspen Institute, Skin care, NIOD, Advisory Committee, Business, Breast, Silicon, Fleming Companies, Inc, Stanford Graduate School of Education, PARIS, NEXT Woman of the Year awards, Education, Bobbi Brown, Stanford Graduate School of Business, Breast cancer, Board of Governors of the United States Postal Service, Widener University Commonwealth Law School, Economics

Pursuant to the stockholders’ agreement among Lauder family members and the Company, Leonard Lauder has the right to designate two directors of the Company.

Key Points: 
  • Pursuant to the stockholders’ agreement among Lauder family members and the Company, Leonard Lauder has the right to designate two directors of the Company.
  • In addition to his son William P. Lauder, who serves as Executive Chairman, Leonard Lauder has designated his son Gary M. Lauder to serve on the Board.
  • Leonard Lauder formally joined The Estée Lauder Companies in 1958 and served as President from 1972 to 1995 and as Chief Executive Officer from 1982 to 1999.
  • In addition to his activities with The Estée Lauder Companies, Leonard Lauder is extremely involved in the worlds of education, art, politics, and philanthropy.

The North West Company Inc. Second Quarter Results and Conference Call

Retrieved on: 
Thursday, August 24, 2023
Giant, Central Time, Giant Tiger, Alaska Commercial Company, CAD, Food, Name, Fleming Companies, Inc, The North West Company, Corporation

WINNIPEG, Manitoba, Aug. 24, 2023 (GLOBE NEWSWIRE) -- (TSX Symbol: NWC): The North West Company Inc. (“North West”) will host a conference call for its second quarter results on September 13, 2023 at 9:00 a.m. (Central Time).

Key Points: 
  • WINNIPEG, Manitoba, Aug. 24, 2023 (GLOBE NEWSWIRE) -- (TSX Symbol: NWC): The North West Company Inc. (“North West”) will host a conference call for its second quarter results on September 13, 2023 at 9:00 a.m. (Central Time).
  • The North West Company Inc., through its subsidiaries, is a leading retailer of food and everyday products and services to rural communities and urban neighbourhoods in Canada, Alaska, the South Pacific and the Caribbean.
  • North West operates 224 stores under the trading names Northern, NorthMart, Giant Tiger, Alaska Commercial Company, Cost-U-Less and RiteWay Food Markets and has annualized sales of approximately CAD $2.2 billion.
  • For further information, please contact: Amanda E. Sutton, Vice President, Legal and Corporate Secretary of The North West Company Inc. at (204) 934-1756, email [email protected] .

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Bausch Health Companies Inc.(BHC) Investors of a Class Action Lawsuit and Upcoming Deadline

Retrieved on: 
Thursday, August 24, 2023
CASE, LLP, Telephone, COST, BHC, Complaint, Levi, Fleming Companies, Inc, CLASS, NEXT, Court, NYSE, Bausch

NEW YORK, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Bausch Health Companies Inc. ("Bausch" or the "Company") (NYSE: BHC) of a class action securities lawsuit.

Key Points: 
  • NEW YORK, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Bausch Health Companies Inc. ("Bausch" or the "Company") (NYSE: BHC) of a class action securities lawsuit.
  • CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Bausch investors who were adversely affected by alleged securities fraud between August 6, 2020 and May 3, 2023.
  • Follow the link below to get more information and be contacted by a member of our team:
    BHC investors may also contact Joseph E. Levi, Esq.
  • For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

BAUSCH HEALTH COMPANIES INC. (NYSE: BHC) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bausch Health Companies Inc.

Retrieved on: 
Tuesday, August 22, 2023
Probability, BHC, District court, Advertising, Fleming Companies, Inc, Complaint, Defendant, Court, Action Replay, News, NYSE, Financial services, Security (finance), Bausch

NEW YORK, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:

Key Points: 
  • NEW YORK, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
    Do you, or did you, own securities of Bausch Health Companies Inc. (NYSE: BHC)?
  • If you purchased or acquired Bausch securities, and/or would like to discuss your legal rights and options please visit Bausch Health Companies Inc.
  • If you purchased or acquired Bausch securities, and/or would like to discuss your legal rights and options please visit Bausch Health Companies Inc.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

BHC LAWSUIT ALERT: Levi & Korsinsky Notifies Bausch Health Companies Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

Retrieved on: 
Friday, August 18, 2023
CASE, LLP, Telephone, COST, BHC, Complaint, Levi, Fleming Companies, Inc, CLASS, NEXT, Court, NYSE, Bausch

NEW YORK, Aug. 18, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Bausch Health Companies Inc. ("Bausch" or the "Company") (NYSE: BHC) of a class action securities lawsuit.

Key Points: 
  • NEW YORK, Aug. 18, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Bausch Health Companies Inc. ("Bausch" or the "Company") (NYSE: BHC) of a class action securities lawsuit.
  • CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Bausch investors who were adversely affected by alleged securities fraud between August 6, 2020 and May 3, 2023.
  • Follow the link below to get more information and be contacted by a member of our team:
    BHC investors may also contact Joseph E. Levi, Esq.
  • For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

The Estée Lauder Companies Inc. Declares Quarterly Dividend of $.66 Per Share

Retrieved on: 
Friday, August 18, 2023
Cosmetics, Retail, Luxury, Beauty, PARIS, Skin care, NIOD, EL, Bobbi Brown, Aveda, Le Labo, Fleming Companies, Inc, Origin, DECIEM, NYSE, Holding company

The Estée Lauder Companies Inc. (NYSE: EL) will pay a quarterly dividend of $.66 per share on the Company’s Class A and Class B Common Stock on September 15, 2023 to stockholders of record at the close of business on August 31, 2023.

Key Points: 
  • The Estée Lauder Companies Inc. (NYSE: EL) will pay a quarterly dividend of $.66 per share on the Company’s Class A and Class B Common Stock on September 15, 2023 to stockholders of record at the close of business on August 31, 2023.
  • The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers and sellers of quality skin care, makeup, fragrance and hair care products, and is a steward of luxury and prestige brands globally.
  • The Company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown Cosmetics, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, and the DECIEM family of brands, including The Ordinary and NIOD.

BHC DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bausch Health Companies Inc.

Retrieved on: 
Monday, August 14, 2023
Probability, Class, BHC, District court, Advertising, Fleming Companies, Inc, Complaint, Defendant, Court, Action Replay, News, NYSE, Financial services, Security (finance), Bausch

If you purchased or acquired Bausch securities, and/or would like to discuss your legal rights and options please visit Bausch Health Companies Inc.

Key Points: 
  • If you purchased or acquired Bausch securities, and/or would like to discuss your legal rights and options please visit Bausch Health Companies Inc.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • If you purchased or acquired Bausch securities, and/or would like to discuss your legal rights and options please visit Bausch Health Companies Inc.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Cronos Group Reports 2023 Second Quarter Results

Retrieved on: 
Tuesday, August 8, 2023
Capital expenditure, Genetics, Marketing, Patient, Peace, Tax, Cannabinoid, Fleming Companies, Inc, Prescription, Research, CBG, Sale, Fermentation, CBN, Cannabinol, Lemonade, CBC, Investment, SKU, Cannabis, Capital, Depreciation, Growth, Bookkeeping, Drug, Pharmaceutical industry, Cronos

TORONTO, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announces its 2023 second quarter business results.

Key Points: 
  • Furthermore, the weakened Canadian dollar and Israeli shekel against the U.S. dollar during the current period adversely impacted results.
  • Cronos expects to continue to operate the Cronos Fermentation facility with a phased reduction and planned exit by the end of 2023.
  • Cronos Growing Company Inc. (“Cronos GrowCo”) reported to the Company preliminary unaudited net revenue to licensed producers, excluding sales to the Company, of approximately $3.6 million in the second quarter of 2023.
  • ET to discuss 2023 Second Quarter business results.

BAUSCH HEALTH COMPANIES INC. (NYSE: BHC) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bausch Health Companies Inc.

Retrieved on: 
Tuesday, August 8, 2023
Probability, Class, BHC, District court, Advertising, Fleming Companies, Inc, Complaint, Defendant, Court, Action Replay, News, NYSE, Financial services, Security (finance), Bausch

NEW YORK, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:

Key Points: 
  • NEW YORK, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
    Do you, or did you, own securities of Bausch Health Companies Inc. (NYSE: BHC)?
  • If you purchased or acquired Bausch securities, and/or would like to discuss your legal rights and options please visit Bausch Health Companies Inc.
  • If you purchased or acquired Bausch securities, and/or would like to discuss your legal rights and options please visit Bausch Health Companies Inc.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

SEC Obtains Emergency Relief to Halt Utah-Based Company's Crypto Asset Fraud Scheme Involving 18 Defendants

Retrieved on: 
Thursday, August 3, 2023
Blockchain, Ether, The Honourable, Fleming Companies, Inc, Social media, District court, Holland, Mining, Security (finance), Salt Lake Regional Medical Center, Holland & Knight, Douglas v. U.S. District Court ex rel Talk America, Cryptocurrency, Financial adviser, Bitcoin

"We filed this emergency action to protect the victims of the defendants' unlawful actions and stop further harm."

Key Points: 
  • "We filed this emergency action to protect the victims of the defendants' unlawful actions and stop further harm."
  • In total, 18 defendants, including those mentioned above, have been charged with engaging in unregistered securities offerings.
  • The complaint seeks permanent injunctive relief, the return of alleged ill-gotten gains, and civil penalties.
  • Investors who believe they were affected by the DEBT Box offering may visit the receiver's website at www.debtboxreceiver.com or call (305) 349-2134.